|Description||Icatibant(HOE-140) is a selective and specific antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively.|
|Synonyms||HOE140; HOE 140; HOE-140|
Icatibant(HOE-140) is a selective and specific antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively.
ELN441958 is a novel, potent and selective bradykinin B1 receptor antagonist with Ki value of 0.26 nM. It competitively inhibited the binding of the agonist [3H...
Peptide T is an HIV entry inhibitor that acts by blocking chemokine-5 receptors (CCR5), currently under clinical trials for the treatment of HIV-related neurolo...
Fasitibant chloride hydrochloride
Fasitibant chloride is a selective nonpeptide kinin B2 receptor antagonist. Phase II clinical trials for the treatment of Osteoarthritis were discontinued.
MK0686 is a bradykinin B1 receptor antagonist. It exhibits suitable pharmacokinetic properties and efficient ex vivo receptor occupancy for further development ...
Safotibant is a non-peptide bradykinin B1 receptor antagonis. It is used for the topical treatment of diabetic macular oedema. It displayed binding Ki values of...
[Des-Arg9]-Bradykinin is a selective Bradykinin(B1) receptor agonist and increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized a...